Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Price

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
The American Journal of Emergency Medicine|May 25, 2013
Hemodynamic consequences of ketamine vs etomidate for endotracheal intubation in the air medical settingBrian Price, Annette O Arthur, Michael Brunko, et al.
Sexual Health|March 4, 2021
Barriers and facilitators to pre-exposure prophylaxis among African migrants in high income countries: a systematic reviewChido Mwaturura, Michael Traeger, Christopher Lemoh, et al.
Sexual Health|May 20, 2011
HIV seroconversions among male non-occupational post-exposure prophylaxis service users: a data linkage studyAnna B Pierce, Keflemariam Yohannes, Rebecca Guy, et al.
Frontiers in Public Health|September 5, 2022
"How PrEPared are you?": Knowledge of and attitudes toward PrEP among overseas-born and newly arrived gay, bisexual, and other men who have sex with men in AustraliaBudiadi Sudarto, Eric P F Chow, Nicholas Medland, et al.
Sexual Health|December 5, 2016
Comparing non-occupational post-exposure prophylaxis drug regimens for HIV: insights from a linked HIV surveillance systemAnna B Pierce, Carol El-Hayek, Damien McCarthy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 10, 2018
Evaluation of Preexposure (PrEP) Eligibility Criteria, Using Sexually Transmissible Infections as Markers of Human Immunodeficiency Virus (HIV) Risk at Enrollment in PrEPX, a Large Australian HIV PrEP TrialVincent J Cornelisse, Christopher K Fairley, Mark Stoove, et al.
Patient Related Outcome Measures|June 19, 2023
Assessment of Real-World Patient-Reported Outcomes in Patients Initiating Biologic Agents for the Treatment of Autoimmune Diseases: An Observational Study in Four Patient-Powered Research NetworksTimothy Beukelman, Millie D Long, Rennie L Rhee, et al.
Molecular Therapy. Nucleic Acids|April 8, 2026
Safety, efficacy, and distal nerve Schwann cell biodistribution in mice and NHPs to support translation of AAV9 RNAi therapy for CMT1AMarina Stavrou, Lindsay M Wallace, Merlin P Thangaraj, et al.
Frontiers in Pharmacology|December 3, 2019
Transformation of Australian Community Pharmacies Into Good Clinical Practice Compliant Trial Pharmacies for HIV Pre-Exposure ProphylaxisLuxi Lal, Kathleen Ryan, Iris Yi Liu, et al.
JAMA|April 10, 2019
Association of HIV Preexposure Prophylaxis With Incidence of Sexually Transmitted Infections Among Individuals at High Risk of HIV InfectionMichael W Traeger, Vincent J Cornelisse, Jason Asselin, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
The American Journal of Emergency Medicine|May 25, 2013
Hemodynamic consequences of ketamine vs etomidate for endotracheal intubation in the air medical settingBrian Price, Annette O Arthur, Michael Brunko, et al.
Sexual Health|March 4, 2021
Barriers and facilitators to pre-exposure prophylaxis among African migrants in high income countries: a systematic reviewChido Mwaturura, Michael Traeger, Christopher Lemoh, et al.
Sexual Health|May 20, 2011
HIV seroconversions among male non-occupational post-exposure prophylaxis service users: a data linkage studyAnna B Pierce, Keflemariam Yohannes, Rebecca Guy, et al.
Frontiers in Public Health|September 5, 2022
"How PrEPared are you?": Knowledge of and attitudes toward PrEP among overseas-born and newly arrived gay, bisexual, and other men who have sex with men in AustraliaBudiadi Sudarto, Eric P F Chow, Nicholas Medland, et al.
Sexual Health|December 5, 2016
Comparing non-occupational post-exposure prophylaxis drug regimens for HIV: insights from a linked HIV surveillance systemAnna B Pierce, Carol El-Hayek, Damien McCarthy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 10, 2018
Evaluation of Preexposure (PrEP) Eligibility Criteria, Using Sexually Transmissible Infections as Markers of Human Immunodeficiency Virus (HIV) Risk at Enrollment in PrEPX, a Large Australian HIV PrEP TrialVincent J Cornelisse, Christopher K Fairley, Mark Stoove, et al.
Patient Related Outcome Measures|June 19, 2023
Assessment of Real-World Patient-Reported Outcomes in Patients Initiating Biologic Agents for the Treatment of Autoimmune Diseases: An Observational Study in Four Patient-Powered Research NetworksTimothy Beukelman, Millie D Long, Rennie L Rhee, et al.
Molecular Therapy. Nucleic Acids|April 8, 2026
Safety, efficacy, and distal nerve Schwann cell biodistribution in mice and NHPs to support translation of AAV9 RNAi therapy for CMT1AMarina Stavrou, Lindsay M Wallace, Merlin P Thangaraj, et al.
Frontiers in Pharmacology|December 3, 2019
Transformation of Australian Community Pharmacies Into Good Clinical Practice Compliant Trial Pharmacies for HIV Pre-Exposure ProphylaxisLuxi Lal, Kathleen Ryan, Iris Yi Liu, et al.
JAMA|April 10, 2019
Association of HIV Preexposure Prophylaxis With Incidence of Sexually Transmitted Infections Among Individuals at High Risk of HIV InfectionMichael W Traeger, Vincent J Cornelisse, Jason Asselin, et al.
Pageof 3